XML 62 R49.htm IDEA: XBRL DOCUMENT v3.22.1
Equity Method Investments - Additional Information (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 19, 2021
Mar. 31, 2022
Mar. 31, 2021
Dec. 31, 2021
[1]
Schedule Of Equity Method Investments [Line Items]        
Equity method investment   $ 5,940   $ 5,987
Share in net loss of equity method investment   47 $ 5,523  
Related party contract liability, noncurrent portion   $ 12,273   $ 12,273
Joint Venture        
Schedule Of Equity Method Investments [Line Items]        
Percentage of equity stake received   45.00%    
Related party transaction. transaction price $ 12,300      
Related party contract liability, noncurrent portion   $ 12,300    
JV Agreement with Genesis MedTech        
Schedule Of Equity Method Investments [Line Items]        
Equity method investment   5,900    
Share in net loss of equity method investment   $ 47    
JV Agreement with Genesis MedTech | Share Subscription Agreement        
Schedule Of Equity Method Investments [Line Items]        
Ordinary shares issued (in shares) 54,900      
Equity percentage 55.00%      
Cash contribution from exchange of equity $ 15,000      
Percentage of cash contribution received from exchange of equity upon signing of agreement 50.00%      
Percentage of cash contribution receivable from exchange of equity within one year 50.00%      
JV Agreement with Genesis MedTech | License Agreement        
Schedule Of Equity Method Investments [Line Items]        
Ordinary shares issued (in shares) 45,000      
Equity percentage 45.00%      
[1] The condensed consolidated balance sheet as of December 31, 2021 is derived from the audited consolidated financial statements as of that date.